Indefinite Delivery Contract SPE2DR25D3301

The Indefinite Delivery Contract (IDC) SPE2DR25D3301 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has a 30-month base period and three 30-month option periods, running through December 2026.

The original solicitation, expected to be issued in March 2024, is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The purpose is to establish Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, the U.S. Coast Guard, and the U.S. Naval Fleet. The solicitation is an unrestricted, fully competitive acquisition, with the intent to make multiple awards for separate regions. Awards will be made on a lowest price technically acceptable (LPTA) basis, with the possibility of using a reverse auction process to determine the final distribution fees.